Doctor Felix Hofer
Medical University of Vienna, Vienna (Austria)
Prescribing trends of sodium-glucose cotransporter 2 Inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction
Event: ESC Congress 2023
Topic: Antidiabetic Pharmacotherapy
Session: Improving outcomes in heart failure: bench to bedside
Fibroblast growth factor-23 is an independent predictor of hospitalization for heart failure and major cardiovascular adverse events in patients undergoing cardiac surgery
Event: ESC Congress 2022
Topic: Biomarkers
Session: Chronic heart failure - Prognosis and prediction of outcome
Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation - Insights from a cohort study of 7,412 patients with extended follow-up
Event: ESC Congress 2021 - The Digital Experience
Topic: Comorbidities
Session: Diabetes and kidney disease in heart failure: how should we treat the terrible triplets?
The prognostic impact of fibroblast growth factor-23 on cardiovascular death after cardiac surgery
Event: ESC Congress 2021 - The Digital Experience
Topic: Biomarkers
Session: Risk Factors and Prevention ePosters
Prognostic impact of left ventricular thrombus resolution after myocardial infarction on cardiovascular events and mortality
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Acute Coronary Syndromes ePosters
ESC 365 is supported by
